(Q37933378)

25 August 2017

title

Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy (English)

1 reference

25 August 2017

main subject

Clostridium difficile

0 references

author name string

Rachel N King

series ordinal

1

1 reference

25 August 2017

Stephanie L Lager

series ordinal

2

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

31

1 reference

25 August 2017

issue

7

1 reference

25 August 2017

page(s)

642-648

1 reference

Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

A 76-year-old man with recurrent Clostridium difficile-associated diarrhea: review of C. difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Clostridium difficile--more difficult than ever

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Clinical practice. Antibiotic-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

National point prevalence of Clostridium difficile in US health care facility inpatients, 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Proton pump inhibitors and risk for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Recommendations for surveillance of Clostridium difficile-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Does PPI therapy predispose to Clostridium difficile infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Identification of risk factors for the development of clostridium difficile-associated diarrhea following treatment of polymicrobial surgical infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

Clinical recognition and diagnosis of Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.31.7.642

21 January 2018

Identifiers

DOI

10.1592/PHCO.31.7.642

1 reference

25 August 2017

1 reference